Life sciences Kubernetes, built for GxP validation
Biotech, pharma, and clinical research run on data integrity and intellectual property. We build and operate Kubernetes platforms that satisfy GxP validation, 21 CFR Part 11, and HIPAA — while giving your genomics pipelines and drug-discovery AI models the GPU-dense compute they need.
Talk to an engineer who knows life sciencesLife Sciences Infrastructure Demands Validated, IP-Safe Platforms
Life sciences organizations — biotech companies, pharmaceutical manufacturers, contract research organizations, and clinical research platforms — operate under a combination of constraints that few other industries face simultaneously. Every system that touches a regulatory submission must be validated. Every electronic record and signature must satisfy 21 CFR Part 11. Every dataset containing patient information must satisfy HIPAA. And every proprietary compound, model, or unpublished result represents years of R&D investment that cannot leak to a competitor or a misconfigured cloud tenant.
At the same time, the science itself is compute-hungry. Genomics pipelines process terabytes of sequencing data. Computational chemistry and molecular dynamics simulations require dense GPU clusters. AI-driven drug discovery models — from target identification to protein structure prediction — need the same GPU-orchestrated infrastructure that consumer AI companies use, except deployed in an environment a GxP auditor can inspect. Traditional life sciences IT, built around validated on-premises systems and slow change-control cycles, was not designed for this combination of scale and speed.
THNKBIG is a US-based Kubernetes and AI infrastructure consulting firm serving biotech companies, pharmaceutical manufacturers, genomics platforms, and clinical research organizations across Texas, California, Massachusetts, North Carolina, and nationwide.
We work with life sciences technology and R&D IT teams in Austin, Houston, Boston, Cambridge, San Francisco, San Diego, Raleigh-Durham, and throughout the United States to build GxP-validated container platforms that support both regulated production systems and fast-moving research computing — without forcing a choice between the two. Our engineers understand that life sciences infrastructure operates under constraints that generic cloud consultants routinely underestimate: computer system validation, data integrity under ALCOA+, and protection of intellectual property that is often the company's entire enterprise value.
Whether you are a clinical-stage biotech building a genomics pipeline platform, a pharmaceutical manufacturer modernizing a validated manufacturing execution environment, or an AI-driven drug discovery company scaling GPU infrastructure for model training, your Kubernetes platform must satisfy GxP, 21 CFR Part 11, and — where patient data is involved — HIPAA, from day one.
We have designed validated Kubernetes environments with documented change control, built air-gapped and on-premises platforms to protect proprietary compound and model data, and stood up GPU-orchestrated clusters for genomics and computational biology workloads. Our approach is practical: we implement the controls that a GxP or FDA auditor actually verifies, and the GPU infrastructure your data scientists actually need — not a checkbox exercise that slows research without reducing risk.
Life Sciences-Specific Kubernetes Solutions
GxP Computer System Validation on Kubernetes
GxP quality guidelines — Good Manufacturing Practice, Good Laboratory Practice, Good Clinical Practice — require that computer systems supporting regulated processes remain in a known, documented, controlled state. Kubernetes's native elasticity and continuous deployment model must be constrained and documented to satisfy this expectation.
We design validated Kubernetes environments with:
- Policy-as-code guardrails (OPA/Kyverno) enforcing approved configurations
- GitOps-driven change control mapped to IQ/OQ/PQ evidence
- Reproducible, versioned builds so every production change is traceable to an approved commit
Our clients maintain validated status on Kubernetes platforms while still shipping platform improvements on a regular cadence — proving that validation and velocity are not mutually exclusive.
Genomics and HPC Pipeline Infrastructure
Sequencing pipelines and computational biology workloads run on orchestration frameworks like Nextflow, Cromwell, and nf-core — tools that expect bursty, high-throughput compute very different from steady-state application traffic.
We help genomics and research computing teams by:
- Running Nextflow/Cromwell/nf-core pipelines natively on Kubernetes with autoscaling tuned for burst workloads
- Configuring NVIDIA GPU Operator and MIG partitioning for cost-efficient GPU sharing across research teams
- Building storage architectures that keep pace with terabyte-scale sequencing data throughput
Our team understands that research computing infrastructure operates under cost and elasticity constraints that pure enterprise IT approaches ignore.
AI-Driven Drug Discovery and GPU Infrastructure
AI is transforming drug discovery — from target identification and protein structure prediction to generative molecule design. But training and serving these models requires GPU infrastructure that satisfies both data scientists and the teams protecting proprietary compound data.
We build GPU-orchestrated Kubernetes platforms for drug discovery AI with:
- Model versioning and governance separating validated from experimental workloads
- Air-gapped or on-premises options for IP-sensitive model training
- Support for the full ML lifecycle from experimentation through validated production deployment
- Audit trails that satisfy regulatory and IP-protection requirements
Clinical Trial Data Platforms and Interoperability
Clinical research platforms — EDC systems, eTMF platforms, and clinical data warehouses — must satisfy HIPAA where patient data is involved, and 21 CFR Part 11 where electronic records feed a regulatory submission.
Our clinical trial data solutions include:
- Kubernetes platforms that host EDC and eTMF systems with encrypted data pipelines
- Secure API gateways with proper authentication for site and sponsor access
- ALCOA+-aligned audit logging for electronic records and signatures
- Scalability for multi-site trials without re-architecting the platform
We understand life sciences constraints
Life sciences isn't just another regulated industry. Validation requirements are strict, the science is compute-intensive, and your intellectual property is the business.
Validated systems can't drift
GxP computer system validation assumes a known, controlled state. Kubernetes's default posture — rolling updates, autoscaling, ephemeral pods — looks like uncontrolled change to a validation auditor unless it's documented and gated.
Our Solution
We implement policy-as-code (OPA/Kyverno) and GitOps promotion gates that make every change to a validated environment traceable, approved, and reproducible — satisfying IQ/OQ/PQ expectations without freezing your platform.
21 CFR Part 11 demands provable integrity
Electronic records and electronic signatures used in regulatory submissions must be attributable, legible, contemporaneous, original, and accurate (ALCOA+) — and defensible under FDA inspection. Most container platforms weren't built with this in mind.
Our Solution
We architect immutable audit trails, tamper-evident logging, and signed artifact provenance into the platform layer, so Part 11 compliance is inherited by every application running on it.
Genomics and HPC workloads don't fit generic clusters
Sequencing pipelines, molecular dynamics, and AI-driven drug discovery models need bursty, GPU-dense, high-throughput compute — very different from the steady-state web workloads most Kubernetes platforms are tuned for.
Our Solution
We build GPU-orchestrated clusters (NVIDIA GPU Operator, MIG partitioning, Kubernetes-native schedulers for Nextflow/Cromwell/nf-core) sized for genomics and computational chemistry, with cost controls for bursty research demand.
Your compounds and models are the company
Novel compound data, proprietary AI models, and unpublished trial results are the actual IP of a life sciences company. A cloud misconfiguration or an over-permissive SaaS integration can leak years of R&D investment.
Our Solution
We design air-gapped and on-premises Kubernetes options for the workloads that must never touch a shared cloud tenant, alongside hardened hybrid architectures for everything else.
Why Life Sciences Companies Choose THNKBIG
Deep Validation and Compliance Expertise
Life sciences organizations choose THNKBIG because we combine deep Kubernetes and GPU infrastructure expertise with genuine understanding of GxP validation and FDA regulatory requirements. We do not just configure encryption and call it Part 11 compliant. We implement the full control set that supports computer system validation:
- Policy-as-code change control
- Immutable, tamper-evident audit trails
- ALCOA+-aligned data integrity controls
- Air-gapped and on-prem options for IP protection
When your quality team asks how we satisfy specific GxP or Part 11 requirements, we have detailed answers backed by implementation experience.
Senior, US-Based Platform Engineers
Our team is made up of senior, US-based platform engineers, serving life sciences organizations across Texas, California, Massachusetts, and nationwide. Our life sciences track record includes:
- Designing validated Kubernetes environments for GxP-regulated workloads
- Building air-gapped, on-premises AI infrastructure to protect proprietary compound and model data
- Standing up GPU-orchestrated genomics and drug-discovery compute at research scale
We understand that life sciences R&D IT operates under constraints that generic cloud consultants do not appreciate. When your quality assurance lead asks about validation evidence or your CSO asks how compound data is isolated, we know how to respond. Outcomes vary by environment; references on request.
Nationwide Coverage
For life sciences organizations in Boston, Cambridge, San Diego, Raleigh-Durham, Austin, Houston, San Francisco, and throughout the United States, THNKBIG is the Kubernetes and AI infrastructure partner that understands your validation and IP protection obligations. We help you meet them without sacrificing research velocity, delivering platforms that satisfy auditors while enabling the science.
Purpose-built for life sciences
GxP-Validated Kubernetes Platforms
Container platforms engineered to support computer system validation — documented change control, IQ/OQ/PQ evidence, and reproducible builds for GMP, GLP, and GCP environments.
Genomics & HPC Pipeline Infrastructure
Kubernetes-native execution for Nextflow, Cromwell, and nf-core genomics pipelines, plus HPC scheduling for computational chemistry and molecular dynamics workloads.
Clinical Trial Data Platforms
Secure, HIPAA-aware infrastructure for EDC systems, eTMF platforms, and clinical data warehouses — built for the data integrity and traceability regulators expect.
Air-Gapped & On-Prem AI Infrastructure
GPU clusters for drug discovery and AI model training that never leave your walls — protecting proprietary compounds, models, and research from shared-tenant exposure.
Biotech research platform moves to a validated, air-gapped Kubernetes environment
Clinical-stage biotech (name under NDA)
The Challenge
A clinical-stage biotech running genomics pipelines and early drug-discovery ML models needed a Kubernetes platform that could support GxP computer system validation and 21 CFR Part 11 evidence requirements, while keeping proprietary compound data off shared cloud infrastructure.
Our Approach
- Designed an air-gapped, on-prem Kubernetes environment for IP-sensitive research workloads
- Implemented policy-as-code (OPA/Kyverno) and GitOps promotion gates for change control
- Built immutable, tamper-evident audit logging aligned to ALCOA+ principles
- Stood up GPU-orchestrated compute for genomics pipelines and model training
- Produced validation-ready documentation packages for the client's quality team
Results
Faster
Validation evidence turnaround
Zero
Shared-tenant exposure for IP
Elastic
GPU capacity for research bursts
Audit-ready
Change control from day one
Outcomes vary by environment; references on request.
Frequently asked questions
What does GxP compliance mean for a Kubernetes platform?
GxP (Good Manufacturing/Laboratory/Clinical Practice) requires that computer systems supporting regulated processes be validated — meaning changes are documented, tested, and approved before they reach production. On Kubernetes, that means policy-as-code guardrails, GitOps-driven change control, immutable audit trails, and IQ/OQ/PQ documentation that maps cluster and application changes to your quality management system.
How do you handle 21 CFR Part 11 electronic records and signatures?
We architect the platform layer so electronic records inherit ALCOA+ properties — attributable, legible, contemporaneous, original, and accurate — by default. That includes tamper-evident logging, signed artifact provenance, RBAC tied to individual identity (not shared service accounts), and retention policies that satisfy FDA inspection requirements.
Can you run genomics pipelines like Nextflow or Cromwell on Kubernetes?
Yes. We build Kubernetes-native execution environments for nf-core and other Nextflow/Cromwell-based genomics pipelines, with GPU Operator integration, MIG partitioning for efficient GPU sharing, and autoscaling tuned for the bursty, high-throughput nature of sequencing and computational biology workloads.
Do you support air-gapped or on-premises deployments?
Yes. For life sciences organizations whose IP — proprietary compounds, unpublished trial data, or AI models — cannot touch shared cloud infrastructure, we design air-gapped and on-premises Kubernetes environments alongside hybrid architectures for less sensitive workloads.
How do you handle HIPAA for clinical trial data?
Clinical trial platforms that touch patient-level data need HIPAA technical safeguards: access controls, audit logging, encryption at rest and in transit, and secure transmission. We implement these controls directly in the Kubernetes platform layer so EDC systems, eTMF platforms, and clinical data warehouses built on top inherit them by default.
What about GPU infrastructure for AI-driven drug discovery?
We build GPU-orchestrated Kubernetes clusters for computational chemistry, molecular dynamics, and generative/predictive drug-discovery models — with NVIDIA GPU Operator, MIG-based GPU partitioning for cost efficiency, and model governance so validated and experimental workloads stay clearly separated.
Technology Partners
Related Reading
GxP-Validated Cloud Infrastructure for Life Sciences Organizations
Life sciences organizations operate under a uniquely demanding combination of regulatory validation requirements and compute-intensive research workloads. GxP quality guidelines — covering Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice — require that computer systems supporting regulated processes remain validated: changes are documented, tested, and approved through a controlled process before reaching production. In Kubernetes environments, satisfying this expectation means implementing policy-as-code guardrails that enforce approved configurations, GitOps-driven promotion pipelines that map every change to an approval record, and reproducible, versioned builds that give quality teams the IQ/OQ/PQ evidence a GxP audit demands. THNKBIG's life sciences practice implements these controls systematically — ensuring Kubernetes infrastructure satisfies GxP validation expectations while maintaining the operational efficiency that R&D engineering teams require.
Electronic records and electronic signatures used in regulatory submissions must satisfy 21 CFR Part 11 and the ALCOA+ data integrity principles — attributable, legible, contemporaneous, original, and accurate, plus complete, consistent, enduring, and available. THNKBIG has implemented Kubernetes-based platforms that build these properties into the infrastructure layer: individually attributed access control instead of shared service accounts, tamper-evident and immutable audit logging, signed artifact provenance for validated builds, and retention policies aligned to FDA inspection expectations. Where clinical trial data is involved, we layer HIPAA technical safeguards — access controls, encryption at rest and in transit, and comprehensive audit trails — on top of the same platform, so EDC systems, eTMF platforms, and clinical data warehouses inherit compliant infrastructure rather than bolting it on application by application.
Genomics sequencing pipelines, computational chemistry, and AI-driven drug discovery represent some of the most compute-intensive workloads life sciences IT teams manage. THNKBIG architects Kubernetes-native execution for Nextflow, Cromwell, and nf-core genomics pipelines, with GPU-orchestrated clusters — using the NVIDIA GPU Operator and MIG partitioning — sized for molecular dynamics simulation and generative or predictive drug-discovery models. For the workloads where intellectual property protection outweighs cloud convenience — proprietary compound libraries, unpublished trial results, in-training AI models — we design air-gapped and on-premises Kubernetes environments that never touch a shared cloud tenant. Our life sciences clients across Texas, California, Massachusetts, and the broader United States have built validated Kubernetes platforms that support GxP audits, protect the intellectual property that represents their core enterprise value, and give research teams the GPU-dense compute modern drug discovery requires. Outcomes vary by environment; references on request.
Ready to make AI operational?
Whether you're planning GPU infrastructure, stabilizing Kubernetes, or moving AI workloads into production — we'll assess where you are and what it takes to get there.
US-based team · All US citizens · Continental United States only